Lancet HIV SCIE
柳叶刀艾滋病毒
2352-3018
No
LANCET HIV
0
50
ENGLAND
http://www.journals.elsevier.com/the-lancet-hiv/
13.0影响因子
免疫学小学科
3/137JIF RANK
6195总被引频次
2352-3018
No
LANCET HIV
0
50
ENGLAND
http://www.journals.elsevier.com/the-lancet-hiv/
13.0影响因子
免疫学小学科
3/137JIF RANK
6195总被引频次
《柳叶刀》艾滋病毒于2014年9月作为一份独家在线杂志发行，出版原创研究、专家评论、内容丰富的社论和及时通信。该月刊为读者提供了背景和洞察的临床进展和实践变化的研究塑造了今天的艾滋病毒/艾滋病的研究。按照《柳叶刀》的传统，该杂志经过严格编辑和同行评审，以确保科学价值和临床相关性。所有的原创研究都将在提交后8周内接受同行评审，并通过我们的在线平台thelancet.com和ScienceDirect在全球范围内接触医学艾滋病毒/艾滋病社区。选择具有高影响力的研究,《华尔街日报》新闻办公室致力于促进世界范围内的媒体报道,确保广泛的全球接触你的研究。
http://ees.elsevier.com/thelancethiv/
The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical HIV/AIDS community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.
